Prognostic value of the miRNA-27a and PPAR/RXRα signaling axis in patients with thyroid carcinoma

Epigenomics. 2020 Oct;12(20):1825-1843. doi: 10.2217/epi-2020-0167. Epub 2020 Sep 24.

Abstract

The authors aimed to evaluate the prognostic value of miRNA-27a (miR-27a), peroxisome proliferator-activated receptor alpha/gamma (PPARα/γ) and retinoid X receptor alpha (RXRα) tissue expression in patients with thyroid carcinoma. The expression levels were quantified in 174 archived thyroid specimens using real-time quantitative PCR. Downregulation of miR-27a was associated with lymph node stage and multifocality. PPARα expression was associated with histopathological type, tumor size and lymph node invasion. Moreover, RXRα expression was lower in patients who underwent total/subtotal thyroidectomy or received radioactive iodine treatment. Patients with upregulated miR-27a and downregulated RXRα showed a higher frequency of advanced lymph node stage and relapse by cluster analysis. Both miR-27a and PPARα/RXRα showed association with different poor prognostic indices in thyroid cancer patients.

Keywords: PPAR; RXR; bioinformatics analysis; cluster analysis; gene expression; miRNA-27a; prognosis; qRT-PCR; thyroid carcinoma.

MeSH terms

  • Adult
  • Carcinoma / genetics
  • Carcinoma / metabolism
  • Carcinoma / mortality
  • Carcinoma / pathology*
  • Female
  • Gene Expression
  • Humans
  • Male
  • MicroRNAs / metabolism*
  • Middle Aged
  • Peroxisome Proliferator-Activated Receptors / genetics
  • Peroxisome Proliferator-Activated Receptors / metabolism*
  • Prognosis
  • Retinoid X Receptor alpha / genetics
  • Retinoid X Receptor alpha / metabolism*
  • Signal Transduction
  • Thyroid Neoplasms / genetics
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / mortality
  • Thyroid Neoplasms / pathology*

Substances

  • MIRN27 microRNA, human
  • MicroRNAs
  • Peroxisome Proliferator-Activated Receptors
  • RXRA protein, human
  • Retinoid X Receptor alpha